Zhengye Biotechnology Holding Ltd is a company mainly engaged in the research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock. The Company markets a diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The Company owns about 44 veterinary vaccines in its product portfolio, which cover veterinary vaccines for livestock, including monovalent vaccine, polyvalent vaccine, combined vaccine and combined and polyvalent vaccine. The Company also engages in vaccines for treating livestock. The Company mainly conducts its business in the domestic market. The Company mainly conducts its business in the domestic and overseas market.
äŒæ¥ã³ãŒãZYBT
äŒç€ŸåZhengye Biotechnology Holding Ltd
äžå Žæ¥Jan 07, 2025
æé«çµå¶è²¬ä»»è
ãCEOãHan (Aiden)
åŸæ¥å¡æ°277
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Jan 07
æ¬ç€Ÿæåšå°No.1 Lianmeng Street, Jilin Economic &
éœåžJILIN
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœChina
éµäŸ¿çªå·132101
é»è©±çªå·
ãŠã§ããµã€ãhttps://www.jlzybio.com./
äŒæ¥ã³ãŒãZYBT
äžå Žæ¥Jan 07, 2025
æé«çµå¶è²¬ä»»è
ãCEOãHan (Aiden)